Complete Filing Data
NOVARTIS AG reported Cash And Cash Equivalents of $11.44 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NOVARTIS AG did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Sale Of Goods | $54.53B | $50.32B | $45.44B | $42.21B | $42.78B | $48.66B | $47.50B | $44.83B | $42.38B | $48.52B |
| Research And Development Expense | $11.20B | $10.02B | $11.37B | $9.17B | $8.64B | $8.98B | $9.40B | $8.49B | $8.39B | $9.04B |
| Profit Loss From Operating Activities | $17.64B | $14.54B | $9.77B | $7.95B | $10.06B | $10.15B | $9.09B | $8.40B | $8.70B | $8.27B |
| Profit Loss Before Tax | $16.35B | $13.64B | $9.12B | $7.18B | $24.53B | $9.88B | $8.94B | $14.10B | $9.10B | $7.82B |
| Profit Loss Attributable To Owners Of Parent | $13.98B | $11.94B | $14.85B | $6.96B | $24.02B | $8.07B | $11.73B | $12.61B | $7.70B | $6.71B |
| Profit Loss | $13.97B | $11.94B | $14.85B | $6.96B | $24.02B | $8.07B | $11.74B | $12.61B | $7.70B | $6.70B |
| Other Revenue | $2.14B | $1.41B | $1.22B | $1.26B | $1.19B | $1.24B | $1.18B | $1.27B | $1.02B | $918.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | $2.80B | -$1.50B | $1.33B | -$359.0M | -$4.50B | $2.94B | $304.0M | -$60.0M | $1.99B | -$1.82B |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $1.16B | $2.02B | -$160.0M | -$103.0M | $1.81B | $143.0M | -$467.0M | -$359.0M | $851.0M | -$515.0M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $3.03B | -$1.57B | $1.38B | -$450.0M | -$4.76B | $3.19B | $352.0M | $315.0M | $2.21B | -$2.39B |
| Other Comprehensive Income | $3.99B | $589.0M | $1.20B | -$844.0M | -$2.50B | $3.33B | -$210.0M | -$406.0M | $2.84B | -$2.33B |
| Interest Expense | $1.14B | $1.01B | $855.0M | $800.0M | $787.0M | $869.0M | $850.0M | $932.0M | $750.0M | $707.0M |
| Income Taxes Paid Refund Classified As Operating Activities | $2.56B | $2.26B | $2.79B | $1.70B | $1.86B | $1.83B | $1.88B | $1.51B | $1.49B | $2.11B |
| Income Tax Expense Continuing Operations | $2.39B | $1.70B | $551.0M | $1.13B | $1.63B | $1.81B | $1.79B | $1.30B | $1.60B | $1.12B |
| Gross Profit | $42.98B | $38.90B | $34.19B | $31.88B | $32.24B | $34.78B | $34.25B | $31.59B | $29.77B | $31.92B |
| Cost Of Sales | $13.70B | $12.83B | $12.47B | $11.58B | $11.74B | $15.12B | $14.43B | $14.51B | $13.63B | $17.52B |
| Comprehensive Income Attributable To Owners Of Parent | $17.97B | $12.53B | $16.05B | $6.12B | $21.53B | $11.40B | $11.53B | $12.21B | $10.54B | $4.38B |
| Comprehensive Income Attributable To Noncontrolling Interests | -$12.0M | -$5.0M | $6.0M | -$5.0M | -$7.0M | -$2.0M | $2.0M | -$2.0M | $2.0M | -$17.0M |
| Comprehensive Income | $17.96B | $12.53B | $16.06B | $6.11B | $21.52B | $11.40B | $11.53B | $12.21B | $10.54B | $4.37B |
| Adjustments For Reconcile Profit Loss | $11.23B | $10.23B | $10.37B | $10.63B | -$6.43B | $9.88B | $9.12B | $1.49B | $5.79B | $8.44B |
| Profit Loss Attributable To Noncontrolling Interests | -$17.0M | -$2.0M | $4.0M | $0.00 | -$3.0M | -$1.0M | $5.0M | $3.0M | $0.00 | -$14.0M |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$12.0M | -$38.0M | -$13.0M | -$11.0M | $15.34B | $673.0M | $659.0M | $6.44B | $1.11B | $703.0M |
| Selling General And Administrative Expense | $13.25B | $12.57B | $12.52B | $12.19B | $12.83B | $14.20B | $14.37B | $13.72B | $12.47B | $14.19B |
| Other Comprehensive Income Net Of Tax Hedges Of Net Investments In Foreign Operations | -$232.0M | $91.0M | -$50.0M | $91.0M | $216.0M | -$201.0M | $44.0M | $95.0M | -$237.0M | |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | $1.19B | $2.09B | -$123.0M | -$485.0M | $2.00B | $393.0M | -$514.0M | -$346.0M | $851.0M | -$515.0M |
| Other Comprehensive Income Net Of Tax Gains Losses From Investments In Equity Instruments | $39.0M | $64.0M | $37.0M | -$382.0M | $194.0M | $250.0M | -$47.0M | $13.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $11.44B | $11.46B | $13.39B | $7.52B | $12.41B | $9.66B | $11.11B | $13.27B | $8.86B | $7.01B | $4.67B |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $1.55B | $1.37B | $1.06B | $916.0M | $1.07B | $1.28B | $1.38B | $1.25B | $1.33B | $1.86B | |
| Purchase Of Intangible Assets Classified As Investing Activities | $2.35B | $2.45B | $1.69B | $1.32B | $1.49B | $1.31B | $878.0M | $1.39B | $969.0M | $1.02B | |
| Payments Out Of Provisions And Other Net Cash Movements In Noncurrent Liabilities | $1.48B | $1.11B | $1.53B | $774.0M | $775.0M | $2.44B | $924.0M | $638.0M | $829.0M | $1.54B | |
| Other Inflows Outflows Of Cash Classified As Financing Activities | -$203.0M | $86.0M | $192.0M | -$38.0M | $72.0M | -$147.0M | $56.0M | $67.0M | $314.0M | $7.0M | |
| Changes In Equity | -$15.53B | -$15.15B | -$28.73B | -$14.51B | -$10.37B | -$10.29B | -$34.67B | -$7.80B | -$11.20B | -$6.60B | |
| Change In Net Current Assets And Other Operating Cash Flow Items | -$1.58B | -$706.0M | -$369.0M | -$796.0M | -$73.0M | -$291.0M | $199.0M | $576.0M | $332.0M | -$77.0M | |
| Cash Flows From Used In Investing Activities | -$4.88B | -$7.51B | $5.60B | $1.47B | $4.21B | -$13.18B | -$2.23B | -$5.59B | -$3.12B | -$3.44B | |
| Cash Flows From Used In Increase Decrease In Current Borrowings | $5.0M | $958.0M | $546.0M | $252.0M | -$3.55B | $2.26B | -$1.58B | $1.69B | -$644.0M | $1.82B | |
| Cash Flows From Used In Financing Activities | -$14.87B | -$11.74B | -$14.28B | -$20.56B | -$16.26B | -$2.21B | -$13.63B | -$4.24B | -$7.73B | -$5.31B | |
| Cash Flows Before Working Capital And Provision Changes | $22.20B | $19.43B | $16.12B | $14.61B | $14.21B | $16.38B | $14.27B | $13.11B | $11.92B | $13.09B | |
| Net Cash Flows Used In Acquisitions And Divestments Of Businesses Classified As Investing Activities | -$3.91B | -$3.56B | -$840.0M | -$205.0M | -$9.96B | -$3.76B | -$13.68B | -$714.0M | -$765.0M | ||
| Cash Flows From Used In Operating Activities | $19.14B | $17.62B | $14.46B | $14.24B | $15.07B | $13.65B | $13.63B | $14.27B | $12.62B | $11.48B | |
| Cash Flows From Used In Investing Activities Continuing Operations | -$4.88B | -$7.51B | $6.72B | $1.90B | $4.90B | -$13.06B | -$1.07B | -$4.59B | -$2.34B | -$2.69B | |
| Increase Decrease Through Transfers And Other Changes Equity | $100.0M | $154.0M | $129.0M | $217.0M | $48.0M | $18.0M | $22.0M | $38.0M | |||
| Dividends Paid To Equity Holders Of Parent Classified As Financing Activities | $7.82B | $7.62B | $7.26B | $7.51B | $7.37B | $6.99B | $6.65B | $6.97B | $6.50B | $6.48B | |
| Cash Flows From Used In Financing Activities Continuing Operations | -$14.87B | -$11.74B | -$17.56B | -$20.68B | -$16.29B | -$2.16B | -$16.88B | -$4.08B | -$7.32B | ||
| Purchase Of Other Longterm Assets Classified As Investing Activities | $1.0M | $59.0M | $61.0M | $60.0M | $39.0M | $40.0M | $149.0M | ||||
| Property Plant And Equipment | $10.78B | $9.46B | $9.51B | $10.76B | $11.55B | $12.26B | $12.07B | $15.70B | $16.46B | ||
| Cash Flows From Used In Investing Activities Discontinued Operations | -$1.12B | -$436.0M | -$689.0M | -$127.0M | -$1.16B | -$1.00B | -$775.0M | -$748.0M | |||
| Rightofuse Assets | $1.57B | $1.42B | $1.41B | $1.43B | $1.56B | $1.68B | $1.68B | $1.55B | |||
| Purchase Of Investments Other Than Investments Accounted For Using Equity Method | $116.0M | $193.0M | $106.0M | $115.0M | $188.0M | $230.0M | $302.0M | ||||
| Cash Flows From Used In Operating Activities Continuing Operations | $19.14B | $17.62B | $14.22B | $13.04B | $13.37B | $13.65B | $13.55B | $13.05B | $11.42B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $13.0M | $86.0M | $237.0M | $158.0M | $211.0M | $88.0M | $857.0M | $102.0M | $91.0M | $161.0M |
| Payments To Acquire Or Redeem Entitys Shares | 9.21B | 8.33B | 8.72B | 10.65B | 3.06B | 2.84B | 5.53B | 2.04B | 5.49B | 1.11B |
| Increase Decrease In Cash And Cash Equivalents | -$24.0M | -$1.93B | $5.88B | -$4.89B | $2.75B | -$1.45B | -$2.16B | $4.41B | $1.85B | $2.33B |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $576.0M | -$298.0M | $100.0M | -$32.0M | -$266.0M | $286.0M | $69.0M | -$26.0M | $84.0M | -$387.0M |
| Proceeds From Sales Of Intangible Assets Classified As Investing Activities | $164.0M | $80.0M | $1.96B | $170.0M | $686.0M | $380.0M | $973.0M | $823.0M | $640.0M | $847.0M |
| Proceeds From Exercise Options And Other Treasury Share Transactions | $27.0M | $30.0M | $153.0M | $100.0M | $53.0M | $748.0M | $201.0M | $700.0M | $252.0M | $214.0M |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$600.0M | -$1.64B | $5.78B | -$4.86B | $3.02B | -$1.74B | -$2.23B | $4.44B | $1.77B | |
| Payments Of Lease Liabilities Classified As Financing Activities | $281.0M | $262.0M | $258.0M | $262.0M | $278.0M | $312.0M | $273.0M | |||
| Proceeds From Noncurrent Borrowings | $6.10B | $6.14B | $16.0M | $16.0M | $7.13B | $93.0M | $2.86B | $4.93B | $1.94B | |
| Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities | $1.97B | $2.74B | $11.25B | $39.36B | $2.30B | $492.0M | $2.56B | |||
| Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method | $209.0M | $957.0M | $348.0M | $133.0M | $440.0M | $723.0M | $1.15B |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $7.15 | $5.87 | $7.10 | $3.17 | $10.63 | $3.52 | $5.06 | $5.38 | $3.25 | $2.80 |
| Basic Earnings Loss Per Share | $7.21 | $5.92 | $7.15 | $3.19 | $10.71 | $3.55 | $5.12 | $5.44 | $3.28 | $2.82 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Purchase Of Treasury Shares | 9.12B | 8.45B | 8.52B | 10.91B | 2.92B | 3.06B | 5.51B | 1.97B | 5.57B | 992.0M | |
| Other Income | $1.46B | $1.18B | $1.77B | $696.0M | $1.62B | $1.74B | $2.03B | $1.63B | $1.92B | $1.93B | |
| Other Finance Income Cost | -$136.0M | $140.0M | $222.0M | $42.0M | -$76.0M | -$78.0M | $45.0M | $186.0M | $42.0M | -$447.0M | |
| Other Expense By Function | $2.34B | $2.94B | $2.30B | $3.26B | $2.34B | $3.19B | $3.43B | $2.61B | $2.14B | $2.34B | |
| Interest Received Classified As Operating Activities | $310.0M | $489.0M | $645.0M | $252.0M | $11.0M | $47.0M | $214.0M | $241.0M | $97.0M | $43.0M | |
| Interest Paid Classified As Operating Activities | $981.0M | $855.0M | $751.0M | $667.0M | $643.0M | $703.0M | $793.0M | $816.0M | $697.0M | $723.0M | |
| Dividends Received Classified As Operating Activities | $1.0M | $1.0M | $2.0M | $1.0M | $523.0M | $490.0M | $463.0M | $719.0M | $987.0M | $899.0M | |
| Repayments Of Noncurrent Borrowings | $3.39B | $2.16B | $2.22B | $2.58B | $2.16B | $2.00B | $3.20B | $366.0M | $188.0M | $1.70B | |
| Finance Costs Paid Classified As Operating Activities | $26.0M | $116.0M | $17.0M | $26.0M | $297.0M | $39.0M | $33.0M | $31.0M | $270.0M | $155.0M | |
| Treasury Shares | 50.0M | 53.0M | 41.0M | 92.0M | 48.0M | 53.0M | 80.0M | 69.0M | 100.0M | 76.0M | 101.0M |
| Issued Capital | $766.0M | $793.0M | $825.0M | $890.0M | $901.0M | $913.0M | $936.0M | $944.0M | $969.0M | $972.0M | $991.0M |
| Increase Decrease Through Sharebased Payment Transactions | $1.16B | $1.06B | $904.0M | $854.0M | $745.0M | $730.0M | $833.0M | $756.0M | $612.0M | $664.0M | |
| Divestments Aquisitions Of Interests In Associated Companies | -$10.0M | -$11.0M | -$24.0M | $20.67B | -$7.0M | -$6.0M | $12.85B | $29.0M | |||
| Dividends Paid | $7.82B | $7.62B | $7.26B | $7.51B | $7.37B | $6.99B | $6.65B | $6.97B | $6.50B | $6.48B | |
| Taxes On Treasury Shares | 113.0M | 68.0M | -14.0M | -14.0M | -1.0M | -32.0M | 189.0M | ||||
| Increase Decrease Through Exercise Of Options | $146.0M | $88.0M | $39.0M | $806.0M | $210.0M | $434.0M | $255.0M | ||||
| Purchase Of Financial Instruments Classified As Investing Activities | $187.0M | $3.46B | $641.0M | $34.70B | $16.40B | $1.90B | $228.0M |
Most recent annual filing with the SEC: February 4, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.